MSC Cruises reveals health protocols developed for Mediterranean cruising

In the wake of unwelcome news this weekend, in which Hurtigruten and Paul Gauguin both reported outbreaks of Covid-19 onboard, MSC Cruises today shared details about how its "Cruise With Confidence" initiative will work in order to resume sailing. A specific target date for its first sailings, in the Mediterranean, has not yet been announced by MSC

At a press conference today in Italy, MSC Cruises' CEO Gianni Onorato laid out a plan that included pillars such as a comprehensive health and safety operating protocol, technology that will support new procedures in a passenger- and crew-focused manner, and details about its group of experts.

Key points that emerged from the press conference:

In addition to a dedicated task force that will develop the new protocols, MSC Cruises is in conversations with RINA, the independent maritime certification corporation. RINA has verified that protocol meets the European Maritime Safety Agency (EMSA) Guidance, which incorporates additional health standards including those from the EU Healthy Gateways Joint Action

While awaiting the necessary final approvals, two MSC Cruises’ ships are making preparations – flagship MSC Grandiosa and popular ship MSC Magnifica. MSC Grandiosa will offer 7-night cruises in the Western Mediterranean and MSC Magnifica will serve the East Mediterranean. Their actual departure dates will be determined in accordance with the guidelines received by the relevant authorities. The itineraries that are planned include Greece and Malta where the authorities have not only re-opened their ports to cruising but also have approved the health and safety protocol to support MSC Cruises’ restart of operations.

MSC revealed key strategies that are part of the new series of protocols. These include:

Universal health screening of guests prior to embarkation that comprises three comprehensive steps: a temperature check, a health questionnaire and a COVID-19 swab test. Depending on the screening results and according to the guest’s medical or travel history, a secondary health screening or testing will take place. Any guest who tests positive, displays symptoms or a temperature will be denied boarding. Following guidelines from the European Centre for Disease Prevention and Control, guests traveling from countries categorized as high risk will be required to take a molecular RT-PCR test, to be done within 72 hours prior to joining the ship. All crew members will be tested for COVID-19 prior to embarkation as well as regularly during their contract.

Elevated sanitation and cleaning measures supported by the introduction of new cleaning methods, the use of hospital-grade disinfectant products and the sanitation of the air on board with UV-C light technology that kills 99.97% of microbes.

Social distancing will be enabled through the reduction of the overall capacity of guests on board, allowing for more space for guests, approximately 10 m² (about 108 sq. ft) per person based on 70% overall capacity. Venue capacity will be reduced, activities will be modified to allow for smaller groups and guests will be able to pre-book services and activities to manage guest numbers. When social distancing is not possible, guests will be asked to wear a face mask, for instance in the elevators. Face masks will be provided daily to guests in their staterooms and will be available around the ship

Enhanced medical facilities and services with highly qualified staff trained, the necessary equipment to test, evaluate and treat suspected COVID-19 patients and the availability of free treatment at the onboard Medical Center for any guest with symptoms. Dedicated isolation staterooms will be available to enable isolation of any suspected cases and close contacts.

Ongoing health monitoring will be conducted throughout the cruise. Guests and crew will have their temperature checked daily either when they return from ashore or at dedicated stations around the ship to monitor the health status of every guest and crew member. During this initial phase of operations, as a further enhanced measure of protection and to avoid risks to the health of guests and their fellow cruisers, guests will only go ashore as part of an organized MSC Cruises’ excursion. This means that MSC Cruises can protect their health while ashore with excursions that will be delivered with the same high standards of health and safety as on board. We will ensure that transfers are properly sanitized and that there is adequate space. Tour guides and drivers will also undergo health screening and will wear appropriate personal protective equipment (PPE).

A contingency response plan will be activated if a suspected case is identified, in close cooperation with the national health authorities. The suspected case and close contacts will follow isolation measures and may be disembarked according to local and national regulations.

In the U.S., MSC Cruises’ ships will only return to service once the necessary approvals have been received from the relevant local and national authorities, including the CDC, as well as across the regions where the ships will operate.

Hurtigruten temporarily suspends all expedition cruises

As a response to the coronavirus outbreak on board Roald Amundsen, Hurtigruten temporarily suspends all expedition sailings on Roald Amundsen, Fridtjof Nansen and Spitsbergen until further notice.

36 crew members and several guests have tested positive for COVID-19 in the outbreak on board the expedition cruise ship Roald Amundsen.

"The safety and well-being of our guests and crew is Hurtigruten’s number one priority. We are now focusing all available efforts in taking care of our guests and colleagues. We are working closely with the Norwegian National and Local Health Authorities for follow-up, information, further testing, and infection tracking," says CEO in Hurtigruten, Daniel Skjeldam.

"In light of the recent increase in new cases of COVID-19 globally, the only responsible choice is to suspend all expedition sailings until we are absolutely confident, we can carry out our operations in line with all requirements from the Authorities and with the even stricter requirements we have set for ourselves," says CEO in Hurtigruten, Daniel Skjeldam.

Hurtigruten is as of Monday in the process of reaching out to and informing guests booked on the now cancelled voyages.

The decision has no impact on Hurtigruten's coastal Norway operations.

COVID-19 hits Fincantieri interims, but long term targets remain intact

Fincantieri, the Italian shipbuilder that is the world’s largest cruise ship builder, said the COVID-19 had hits its first half interims, but pointed out that no orders had been cancelled and targets of the group’s current business plan remain intact.

Revenues fell by 15.6% to €2.37 billion in the first half of this year from the same period in 2019 as suspension of production in the spring resulted in a €790 reduction in the output. EBITDA fell to €119 million from €227 million and EBITDA margin t 5.0% from 8.1%. The group made a net loss of €137 million, including €114 million impact from cOVID-19 and €23 million from asbestos. In the first half of last year, Fincantieri had booked a net loss of €12 million.

Net debt rose to €980 million as per 30 June from €736 million a year earlier. This mirrors the cruise shipbuilding working capital flow, stressed/accentuated by COVID-19 effects resulting in the postponement of a cruise ship delivery – originally scheduled for the 2020 first semester – and of part of the expected installments, the company said.

Giuseppe Bono, Chief Executive Officer of Fincantieri, said: “It is evident that our economic and financial results are influenced by the production slowdown due to the Coronavirus. However, our current backlog allows us to look at the future with confidence, confirming a workload for the next six to seven years with consequent financial and economic performances in line with the previous Business Plan’s targets.”

The group’s shipyards had orders for 117 ships of various types at the end of June, it said.